THE INDIAN PHARMACIST Official Circular Pharmacy LogoTHE INDIAN PHARMACISTLearn. Explore. Practise. Excel.
Pharmacokinetics, Biopharmaceutics & Clinical Dosing ARTICLE ID: KH-37 ⏱️ 12 min read 📅 Updated: 2026-11-10

Drug Absorption, Distribution, Metabolism and Excretion (ADME) Made Visual

🎯 Key Takeaways Summary

  • Bioavailability (F) is governed by aqueous dissolution, intestinal membrane permeability (BCS Class I–IV), P-gp efflux, and hepatic first-pass CYP450 extraction.
  • Steady state (Css) is reached in 4 to 5 elimination half-lives (94% at 4 t1/2; 97% at 5 t1/2) regardless of the dosing interval.
  • Remember the classic CYP450 Inducers ('CRAP GPS': Carbamazepine, Rifampicin, Alcohol-chronic, Phenytoin, Griseofulvin, Phenobarbitone, St. John's Wort / Enzalutamide) and Inhibitors ('SICKFACES.COM': Sodium valproate, Isoniazid, Cimetidine, Ketoconazole/Itraconazole, Fluconazole, Alcohol-acute, Clarithromycin/Ciprofloxacin, Erythromycin, Sulfonamides, Grapefruit juice, Omeprazole, Metronidazole).
  • Urinary alkalinisation with IV Sodium Bicarbonate traps weak acids (Salicylate, Phenobarbitone, Methotrexate) in the renal tubule in ionised form, accelerating renal elimination.

1. Foundational Clinical & Scientific Overview

Pharmacokinetics ('what the human body does to a drug') traces the 4-stage journey of a medicine from the site of administration to elimination: Absorption (entry from the gut, muscle, skin, or lungs into systemic circulation), Distribution (reversible transfer between plasma and peripheral tissues across biological barriers), Metabolism (enzymatic biotransformation primarily in the liver and intestinal wall), and Excretion (irreversible removal of intact drug and metabolites via urine, bile/faeces, or exhaled air).

2. Core Mechanisms, Classification & Practical Framework

Every pharmacokinetic equation taught in B.Pharm and Pharm.D courses maps directly to a concrete clinical reality: Bioavailability (F) explains why IV Digoxin/Levothyroxine/Etoposide doses differ from oral doses; Volume of Distribution (Vd) determines the Loading Dose and whether a poisoned patient can be dialysed; Clearance (CL) determines the Maintenance Dose; and Elimination Half-Life (t1/2 = 0.693 x Vd / CL) dictates that any drug takes 4 to 5 half-lives to reach Steady State (Css) or to wash out completely after discontinuation.

Structured Classification & Practical Examples

  • 1. ABSORPTION & FIRST-PASS EXTRACTION (Bioavailability F): After an oral tablet disintegrates and dissolves in gastrointestinal fluids, unionised drug molecules cross enterocyte membranes (governed by Henderson-Hasselbalch pKa and pH) while P-glycoprotein (ABCB1) efflux pumps and intestinal CYP3A4 extrude/metabolise a fraction. The absorbed drug then travels via the hepatic portal vein directly through the liver BEFORE reaching systemic arterial blood. Sublingual nitroglycerin, transdermal patches, and intravenous injections bypass hepatic first-pass metabolism.
  • 2. DISTRIBUTION & PLASMA PROTEIN BINDING (Vd = Dose / C0): Acidic drugs (warfarin, phenytoin, NSAIDs, furosemide) bind predominantly to Plasma Albumin, whereas basic drugs (lidocaine, propranolol, imipramine) bind to Alpha-1-Acid Glycoprotein (AAG). Only the UNBOUND (free) drug fraction crosses capillary endothelium, activates pharmacological receptors, or undergoes glomerular filtration. Drugs with huge Vd (>200–500 L, such as Digoxin, Amiodarone, Chloroquine, Tricyclic Antidepressants, and Tigecycline) are sequestered deep inside tissues and CANNOT be removed effectively by haemodialysis!
  • 3. METABOLISM (Phase I Functionalisation vs Phase II Conjugation): Phase I enzymes (Cytochrome P450: CYP3A4/5 ~50% of drugs, CYP2D6 ~25%, CYP2C9, CYP2C19, CYP1A2) introduce or unmask a polar group (-OH, -NH2, -SH) via oxidation, reduction, or hydrolysis, sometimes activating prodrugs (Codeine -> Morphine via CYP2D6; Clopidogrel -> active thiol via CYP2C19; Enalapril -> Enalaprilat via esterases). Phase II transferases (UGT glucuronidation, SULT sulfation, NAT acetylation, GST glutathione conjugation) attach a bulky water-soluble endogenous molecule for rapid excretion.
  • 4. EXCRETION (Renal Nephron Mechanics & Enterohepatic Recycling): Renal clearance combines three nephron processes: Renal Clearance = Glomerular Filtration (free drug only, ~120 mL/min) + Active Proximal Tubular Secretion (via OAT1/3 and OCT2 — blocked competitively by Probenecid or Cimetidine) - Passive Distal Tubular Reabsorption (governed by urine pH trapping: urinary alkalinisation with IV Sodium Bicarbonate ionises weak acids like Salicylates, Phenobarbitone, and Methotrexate, trapping them in urine and accelerating excretion!).

3. Advanced Clinical Pharmacy, Dosing & Indian Regulatory Application

First-Order vs Zero-Order (Michaelis-Menten Saturable) Kinetics: Over 95% of drugs follow Linear First-Order Kinetics (where a constant PERCENTAGE of drug is eliminated per hour, t1/2 is constant, and doubling the dose doubles steady-state plasma concentration). However, three classic entities — Phenytoin, High-Dose Aspirin (Salicylates), and Ethanol — saturate their hepatic metabolic enzymes at therapeutic/supratherapeutic concentrations (Zero-Order / Capacity-Limited Kinetics), where only a constant AMOUNT (mg/hr) can be cleared, causing small dose increments of Phenytoin (e.g., from 300 mg to 350 mg) to trigger a disproportionate, toxic surge in plasma levels!

4. Common Misunderstandings & Pharmacist Safety Safeguards

⚠️ Clinical Pitfall & Safety Note: Common Misunderstanding: Assuming that displacing a highly protein-bound drug from albumin (e.g., adding a second albumin-bound drug) always causes sustained clinical toxicity for all drugs. For low-extraction drugs cleared restrictively by the liver, any transient rise in free fraction is rapidly compensated by an equal increase in hepatic clearance of the free drug, leaving steady-state UNBOUND concentration unchanged (though total measured plasma level drops, as seen with Phenytoin in hypoalbuminaemia!).

5. Explanatory Visual Pharmacology Diagram (svg-v339-01-adme-12-step-journey)

THE 12-STEP ORAL DRUG JOURNEY THROUGH THE HUMAN BODY (LADME) Note: IV bolus enters Step 6 directly (F = 100%); Sublingual & Transdermal routes bypass Step 4–5 Portal First-Pass Metabolism 1. Oral Administration • Tablet / Capsule swallowed • Gastric emptying to duodenum pH 1.5–3.5 (Stomach) 2. Disintegration & Dissolution • Tablet breaks into granules • API dissolves in GI fluid Noyes-Whitney Dissolution Rate 3. GI Epithelial Absorption • Crosses intestinal villi • Passive / Active / P-gp efflux Small Intestine (Large Surface Area) 4. Portal Circulation • Mesenteric veins → Portal vein • Delivers blood to liver sinusoids Pre-systemic Venous Conduit 5. First-Pass Metabolism • Gut & hepatic CYP450 extraction • High: GTN, Propranolol, Morphine Determines Bioavailability (F = f_a × (1-E_H)) 6. Systemic Circulation • Hepatic vein → IVC → Heart • Unbound vs Albumin-bound drug Only FREE drug is active 7–8. Tissue Distribution (Vd) • Capillary permeation to organs • Blood-Brain & Placental barriers Vd = Dose / C_0 (L or L/kg) 9. Target Site of Action • Receptors (GPCR, Ion channel) • Enzymes & Carrier Transporters Pharmacodynamic Effect (E_max, EC50) 10. Hepatic Biotransformation • Phase I (CYP450 Oxidation/Hydrolysis) • Phase II (Glucuronidation/Sulfation) Converts lipophilic drug → hydrophilic metabolite 11. Renal & Biliary Elimination • Nephron: Filtration + Secretion − Reabsorption • Biliary excretion & Enterohepatic recycling Total Clearance CL_tot = CL_renal + CL_hepatic 12. Excretion from the Body • Urine (Primary polar metabolite route) • Bile/Faeces, Expired Air, Sweat, Milk Elimination Half-Life t1/2 = (0.693 × Vd) / CL
8.1 Complete 12-Step Journey of an Orally Administered Drug (ADME): Figure 8.1: The 12-step physiological journey of a typical orally administered solid dosage form through Liberation, Absorption, Distribution, Metabolism, and Excretion (LADME). Note: Parenteral (IV), sublingual, and inhalational routes bypass gastrointestinal absorption and/or hepatic first-pass metabolism.

6. Authoritative References & Editorial Traceability

Primary Reference Sources: Rowland and Tozer's Clinical Pharmacokinetics and Pharmacodynamics; Goodman & Gilman's The Pharmacological Basis of Therapeutics; Visual Pharmacology Library Plates 8.1–8.8.

Official Portals: CDSCO • Indian Pharmacopoeia Commission (IPC / NFI) • ICMR • FSSAI • NCBI Bookshelf

Educational Disclaimer: Published for pharmacy education, academic learning, and professional clinical reference. Never self-medicate or alter prescribed treatment without consulting a qualified medical practitioner.

← Previous: Kidney and Liver Function in Drug Dosing: ... All 40 Articles Next: Common Medication Errors and How Pharmacis... →